Antje Prasse
Antje Prasse
Verified email at
Cited by
Cited by
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18
A Prasse, DV Pechkovsky, GB Toews, W Jungraithmayr, F Kollert, ...
American journal of respiratory and critical care medicine 173 (7), 781-792, 2006
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
NI Chaudhary, GJ Roth, F Hilberg, J Müller-Quernheim, A Prasse, ...
European Respiratory Journal 29 (5), 976-985, 2007
Common patterns and disease-related signatures in tuberculosis and sarcoidosis
J Maertzdorf, J Weiner, HJ Mollenkopf, T Network, T Bauer, A Prasse, ...
Proceedings of the National Academy of Sciences 109 (20), 7853-7858, 2012
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool
MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ...
Sarcoidosis Vasculitis and diffuse Lung Diseases 31 (1), 19-27, 2014
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis
A Prasse, C Probst, E Bargagli, G Zissel, GB Toews, KR Flaherty, ...
American journal of respiratory and critical care medicine 179 (8), 717-723, 2009
Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction
DV Pechkovsky, A Prasse, F Kollert, KMY Engel, J Dentler, W Luttmann, ...
Clinical immunology 137 (1), 89-101, 2010
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells
M Rakhmanov, B Keller, S Gutenberger, C Foerster, M Hoenig, ...
Proceedings of the National Academy of Sciences 106 (32), 13451-13456, 2009
Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids
J Christian Virchow Jr, A Prasse, IAN Naya, L Summerton, A Harris, ...
American journal of respiratory and critical care medicine 162 (2), 578-585, 2000
The pathogenesis of pulmonary fibrosis: a moving target
WA Wuyts, C Agostini, KM Antoniou, D Bouros, RC Chambers, V Cottin, ...
European Respiratory Journal 41 (5), 1207-1218, 2013
Oxidative stress in the pathogenesis of diffuse lung diseases: a review
E Bargagli, C Olivieri, D Bennett, A Prasse, J Muller-Quernheim, P Rottoli
Respiratory medicine 103 (9), 1245-1256, 2009
CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis
A Prasse, DV Pechkovsky, GB Toews, M Schäfer, S Eggeling, C Ludwig, ...
Arthritis & Rheumatism 56 (5), 1685-1693, 2007
Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis
A Prasse, G Zissel, N Lutzen, J Schupp, R Schmiedlin, E Gonzalez-Rey, ...
American journal of respiratory and critical care medicine 182 (4), 540-548, 2010
Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states
U Sester, M Fousse, J Dirks, U Mack, A Prasse, M Singh, A Lalvani, ...
PloS one 6 (3), e17813, 2011
Phenotyping sarcoidosis from a pulmonary perspective
A Prasse, C Katic, M Germann, A Buchwald, G Zissel, ...
American journal of respiratory and critical care medicine 177 (3), 330-336, 2008
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ...
The Lancet Respiratory Medicine 8 (5), 453-460, 2020
Sarcoidosis-immunopathogenetic concepts
G Zissel, A Prasse, J Müller-Quernheim
Seminars in respiratory and critical care medicine 28 (01), 003-014, 2007
Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells
A Prasse, CG Georges, H Biller, H Hamm, H Matthys, W Luttmann, ...
Clinical & Experimental Immunology 122 (2), 241-248, 2000
Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
K Warnatz, HH Peter, M Schumacher, L Wiese, A Prasse, F Petschner, ...
Annals of the rheumatic diseases 62 (1), 50-57, 2003
Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis
JC Schupp, H Binder, B Jäger, G Cillis, G Zissel, J Müller-Quernheim, ...
PloS one 10 (1), e0116775, 2015
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force
RP Baughman, S Nagai, M Balter, U Costabel, M Drent, R Du Bois, ...
Sarcoidosis vasc diffuse lung dis 28 (1), 56-64, 2011
The system can't perform the operation now. Try again later.
Articles 1–20